Active Pharmaceutical Ingredients (API)
Glenmark Life Sciences Limited, is a leading developer and manufacturer of select, high value, non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas such as cardiovascular disease, central nervous system disease, pain management and diabetes. The company is increasingly providing CDMO services to a range of multinational and speciality pharmaceutical companies. The company manufactures and supplies more than 137 high quality APIs to customers worldwide. Glenmark Life Sciences associates with leading global generic companies by supporting partnerships through advanced process chemistry skills and innovative intellectual property.
Its business spans over 65 countries including regulated markets of the US, Canada, Europe and Japan. It is a market leader for many API products in semi-regulated markets and have also established a leadership position with its first-to-file offerings across regulated markets. Its state-of-the-art facilities at Gujarat and Maharashtra in India, collectively manufacture numerous high quality APIs.
GLOBAL PRESENCE
Serving customers in over 80 countries
MANUFACTIRING FACILITIES
Manufacturing high quality APIs across our five state-of-the-art facilities
R&D AND INTELLECTUAL PROPERTY
Supporting our partnerships through advanced process chemistry and strong IP
